Recent events
Recent events tied to this brand in public sources.
Back to profile4 entries
2022
Novartis acquires Gyroscope Therapeutics
Gyroscope Therapeutics was sold to Novartis for up to $1.5 billion, including an $800 million upfront cash payment and up to $700 million in milestone payments.
2020
Freeline prices its U.S. IPO
Freeline Therapeutics Holdings plc priced approximately 8.82 million American Depositary Shares at $18 each for its U.S. initial public offering, aiming to raise approximately $158.8 million in gross proceeds. The shares were expected to begin trading on Nasdaq on August 7.
2020
Syncona appoints Dr Kemal Malik to its board
Syncona announced the appointment of Dr Kemal Malik as a Non-Executive Director with immediate effect.
2020
Autolus prices US public offering; Syncona commits investment
Autolus announced pricing for an underwritten US public offering of 7,250,000 American Depositary Shares at $11.00 per share, with gross proceeds of approximately $80.0 million. Syncona agreed to invest $15.0 million in the offering.